A new study shows a significant benefit in prevention of recurrent venous clots among aspirin users. If confirmed, this would be a major additional benefit for the wonder drug: aspirin!
A commonly-used heart drug, digoxin, has never passed a controlled-study test to see if it s both safe and effective for patients with atrial fibrillation. A large VA retrospective analysis shows that it may be even riskier than suspected: maybe time for it to go.
Two new studies show that sudden-onset strokes are often provoked by the relatively common heartbeat irregularity, atrial fibrillation. If short-term cardiac monitoring fails to detect it, 30-day testing is required. Anticoagulation can be lifesaving.
Neurology group issues new guidelines on stroke prevention among people with irregular heartbeats atrial fibrillation, mainly. In summary: be more aggressive with blood thinners (anticoagulants).